The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes

References

• Adler DA, Bungay KM, Wilson IB, et al. (2004). The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry, 26, 199–209
   PubMed Web of Science ®Google Scholar
• Al-Jumah KA, Qureshi NA. (2012). Impact of pharmacist interventions on patients’ adherence to antidepressants and patient-reported outcomes: A systematic review. J Patient Pref Adher, 6, 87–100
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Sinha A, Hass SL, et al. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outc, 2, 1–13
   PubMedGoogle Scholar
• Australian Government Department of Health. (2016). The Pharmaceutical Benefits Scheme (PBS) – Sertaline. Available from: http://www.pbs.gov.au/medicine/item/2236q-2237r-8836c-8837d
   Google Scholar
• Bell JS, McLachlan AJ, Aslani P, et al. (2005). Community pharmacy services to optimise the use of medications for mental illness: A systematic review. Aust NZ Health Pol, 2, 29–39
   PubMedGoogle Scholar
• Blalock SJ, Roberts AW, Lauffenburger JC, et al. (2013). The effect of community pharmacy-based interventions on patient health outcomes. A systematic review. Med Care Res Rev, 70, 235–66
   PubMed Web of Science ®Google Scholar
• Bond C. (2015). Pharmacy Practice Research: Evidence and Impact. In: Babar Z-U-D, ed. Pharmacy practice research methods. Switzerland: Adis, 1–23
   Google Scholar
• Broadbent E. (2002). The Brief Illness Perception Questionnaire scoring instructions. Available from: http://guild.org.au/services-programs/research-and-development/archive-fourth-agreement/2007-08-08
   Google Scholar
• Broadbent E, Petrie KJ, Mai J, Weinman J. (2006). The Brief Illness Perception Questionnaire. J Psychosom Res, 60, 631–7
   PubMed Web of Science ®Google Scholar
• Brook O, van Hout H, Nieuwenhuyse H, Heerdink E. (2003). Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients: A randomized controlled trial. Eur Neuropsychopharmacol, 13, 1–9
   PubMed Web of Science ®Google Scholar
• Bultman D, Svarstad BL. (2002). Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc, 42, 36–43
   Google Scholar
• Capoccia K, Boudreau D, Blough D, et al. (2004). Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health-Syst Pharm, 61, 364–72
   PubMed Web of Science ®Google Scholar
• Chong WW, Aslani P, Chen TF. (2011). Effectiveness of interventions to improve antidepressant medication adherence: A systematic review. Int J Clin Pract, 65, 954–75
   PubMed Web of Science ®Google Scholar
• Chong WW, Aslani P, Chen TF. (2013). Shared decision-making and interprofessional collaboration in mental healthcare: A qualitative study exploring perceptions of barriers and facilitators. J Interprofess Care, 27, 373–9
   PubMed Web of Science ®Google Scholar
• Cohen J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates
   Google Scholar
• Crockett J, Taylor S, Grabham A, Stanford P. (2006). Patient outcomes following an intervention involving community pharmacists in the management of depression. Aust J Rural Health, 14, 263–9
   PubMedGoogle Scholar
• Elliott RA, Putman K, Davies J, Annemans L. (2014). A review of the methodological challenges in assessing the cost effectiveness of pharmacist interventions. PharmacoEconomics, 32, 1185–99
   PubMed Web of Science ®Google Scholar
• Emmerton LM, Smith L, LeMay KS, et al. (2012). Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Serv Res, 12, 164
   PubMed Web of Science ®Google Scholar
• Feyer AM, Benrimoj SI, Schulman C, et al. (2010). National trial to test strategies to improve medication compliance in a community pharmacy setting. Available from: http://guild.org.au/services-programs/research-and-development/archive-fourth-agreement/2007-08-08
   Google Scholar
• Finley PR, Rens HR, Pont JT, et al. (2003). Impact of a collaborative care model on depression in a primary care setting: A randomized controlled trial. Pharmacotherapy, 23, 1175–85
   PubMed Web of Science ®Google Scholar
• García S, Martínez-Cengotitabengoa M, López-Zurbano S, et al. (2016). Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: A systematic review. J Clin Psychopharmacol, 36, 355–71
   PubMed Web of Science ®Google Scholar
• Guillaumie L, Moisan J, Gregoire JP, et al. (2015). Perspective of community pharmacists on their practice with patients who have an antidepressant drug treatment: Findings from a focus group study. Res Social Adm Pharm, 11, e43–56
   PubMed Web of Science ®Google Scholar
• Happell B, Manias E, Roper C. (2004). Wanting to be heard: Mental health consumers’ experiences of information about medication. Int J Ment Health Nurs, 13, 242–8
   PubMed Web of Science ®Google Scholar
• Hattingh HL, Kelly F, Fowler JL, Wheeler AJ. (2016a). Implementation of a mental health service in community pharmacies: Practice facilitators and challenges. Res Soc Adm Pharm. [Epub ahead of print]. doi:10.1016/j.sapharm.2017.05.017
   Web of Science ®Google Scholar
• Hattingh HL, Scahill S, Fowler JL, Wheeler AJ. (2016b). Exploring an increased role for Australian community pharmacy in mental health professional service delivery: Evaluation of the literature. J Ment Health, 25, 550–9
   PubMed Web of Science ®Google Scholar
• Hattingh HL, Knox K, Fejzic J, et al. (2015). Privacy and confidentiality: Perspectives of mental health consumers and carers in pharmacy settings. Int J Pharm Pract, 23, 52–60
   PubMedGoogle Scholar
• Healthcare Management Advisors. (2010). Managing mental illness and promoting and sustaining recovery: The role of community pharmacy. Available from: http://guild.org.au/services-programs/research-and-development/archive-fourth-agreement/2007-08-07
   Google Scholar
• Horne R, Weinman J, Hankins M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health, 14, 1–24
   Web of Science ®Google Scholar
• Knox K, Kelly F, Mey A, et al. (2015). Australian mental health consumers’ and carers’ experiences of community pharmacy service. Health Expect, 18, 2107–20
   PubMed Web of Science ®Google Scholar
• Kram KE. (1983). Phases of the mentor relationship. Acad Manage J, 26, 608–25
   Web of Science ®Google Scholar
• Krass I, Armour C, Mitchell B, et al. (2007). The Pharmacy Diabetes Care program: Assessment of a community pharmacy diabetes service model in Australia. Diab Med, 24, 677–83
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Islam T, Webber LS, et al. (2009). New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care, 15, 59–66
   PubMed Web of Science ®Google Scholar
• McMillan SS, Kelly F, Sav A, et al. (2014). Australian community pharmacy services: A survey of what people with chronic conditions and their carers use versus what they consider important. BMJ Open, 4, e006587
   PubMed Web of Science ®Google Scholar
• Mey A, Knox K, Kelly F, et al. (2013). Trust and safe spaces: Mental health consumers’ and carers’ relationships with community pharmacy staff. The Patient, 6, 281–9
   PubMedGoogle Scholar
• Mirzaei M, Aspin C, Essue B, et al. (2013). A patient-centred approach to health service delivery: Improving health outcomes for people with chronic illness. BMC Health Serv Res, 13, 251
   PubMed Web of Science ®Google Scholar
• Morgan S, Yoder LH. (2012). A concept analysis of person-centered care. J Holist Nurs, 30, 6–15
   PubMedGoogle Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. (2008). Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens, 10, 348–54
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care, 24, 67–74
   PubMed Web of Science ®Google Scholar
• Morisky DE, DiMatteo MR. (2011). Improving the measurement of self-reported medication nonadherence: Final response. J Clin Epidemiol, 64, 262–3
   Web of Science ®Google Scholar
• Moullin JC, Sabater-Hernandez D, Benrimoj SI. (2016). Model for the evaluation of implementation programs and professional pharmacy services. Res Social Adm Pharm, 12, 515–22
   PubMed Web of Science ®Google Scholar
• Moullin JC, Sabater-Hernandez D, Fernandez-Llimos F, Benrimoj SI. (2013). Defining professional pharmacy services in community pharmacy. Res Soc Adm Pharm, 9, 989–95
   PubMed Web of Science ®Google Scholar
• Naik Panvelkar P, Saini B, Armour C. (2009). Measurement of patient satisfaction with community pharmacy services: A review. Pharm World Sci, 31, 525–37
   PubMedGoogle Scholar
• Neame R, Hammond A. (2005). Beliefs about medications: A questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford), 44, 762–7
   PubMed Web of Science ®Google Scholar
• Rickles NM, Svarstad BL, Statz-Paynter JL, et al. (2005). Pharmacist telemonitoring of antidepressant use: Effects on pharmacist-patient collaboration. J Am Pharm Assoc, 45, 344–53
   Google Scholar
• Rubio-Valera M, March Pujol M, Fernández A, et al. (2013). Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trial. Eur Neuropsychopharmacol, 23, 1057–66
   PubMed Web of Science ®Google Scholar
• Rubio-Valera M, Serrano-Blanco A, Magdalena-Belío J, et al. (2011). Effectiveness of pharmacist care in the improvement of adherence to antidepressants: A systematic review and meta-analysis. Ann Pharmacother, 45, 39–48
   PubMed Web of Science ®Google Scholar
• Scahill S, Fowler JL, Hattingh HL, et al. (2015). Mapping the terrain: A conceptual schema for a mental health medication support service in community pharmacy. SAGE Open Med, 3
   PubMedGoogle Scholar
• The 6CPA. (2015). 6th Community Pharmacy Agreement. Available from: http://6cpa.com.au/
   Google Scholar
• The Pharmacy Guild of Australia & Australian Government Department of Health. (2014a). Community pharmacy service charter. Available from: http://6cpa.com.au/resources/community-pharmacy-service-charter/
   Google Scholar
• The Pharmacy Guild of Australia & Australian Government Department of Health. (2014b). MedsCheck and Diabetes MedsCheck. Available from: http://6cpa.com.au/medication-management-programmes/medscheck-diabetes-medscheck/
   Google Scholar
• Thompson L, McCabe R. (2012). The effect of clinician-patient alliance and communication on treatment adherence in mental healthcare: A systematic review. BMC Psychiatry, 12, 87
   PubMed Web of Science ®Google Scholar
• Vigo D, Thornicroft G, Atun R. (2016). Estimating the true global burden of mental illness. The Lancet Psychiatry, 3, 171–8
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr, Kosinski M, Keller SD. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care, 34, 220–33
   PubMed Web of Science ®Google Scholar
• Wheeler A, Fowler J, Hattingh L, Kelly F. (2015). Exploring the role of community pharmacy in supporting mental health consumers and carers. Available from Canberra: http://6cpa.com.au/resources/fifth-agreement-rd/mental-health-project/
   Google Scholar
• Wheeler A, Fowler J, Hattingh L. (2013). Using an intervention mapping framework to develop an online mental health continuing education program for pharmacy staff. J Contin Educ Health Prof, 33, 258–66
   PubMed Web of Science ®Google Scholar
• Whiteford H, Degenhardt L, Rehm J, et al. (2013). Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet, 382, 1575–86
   PubMed Web of Science ®Google Scholar
• Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LRE. (2016). The effect of knowledge and expectations on adherence to and persistence with antidepressants. Pat Pref Adher, 10, 761–8
   PubMed Web of Science ®Google Scholar
• Young SJ, Praskova A, Hayward N, Patterson S. (2017). Attending to physical health in mental health services in Australia: A qualitative study of service users’ experiences and expectations. Health Soc Care Comm, 25, 602–11
   PubMed Web of Science ®Google Scholar